MCE - Delayed Quote EUR

Clínica Baviera, S.A. (CBAV.MC)

39.00
-0.10
(-0.26%)
At close: May 13 at 5:35:02 PM GMT+2
Loading Chart for CBAV.MC
  • Previous Close 39.10
  • Open 39.20
  • Bid 39.00 x --
  • Ask 39.00 x --
  • Day's Range 38.50 - 40.00
  • 52 Week Range 26.40 - 40.00
  • Volume 1,296
  • Avg. Volume 26,590
  • Market Cap (intraday) 623.739M
  • Beta (5Y Monthly) 0.76
  • PE Ratio (TTM) 15.79
  • EPS (TTM) 2.47
  • Earnings Date May 22, 2025 - May 26, 2025
  • Forward Dividend & Yield 1.57 (4.02%)
  • Ex-Dividend Date Jun 11, 2025
  • 1y Target Est --

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics in Spain and Europe. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, farsightedness, presbyopia, cataract, retinal, plastic surgery, pediatric ophthalmology, glaucoma, strabismus, cornea, neuro-ophthalmology, tear ducts, oculoplasty, lasik, lasek, and intraocular lenses treatments. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and changed its name to Clínica Baviera, S.A. in 2000. Clínica Baviera, S.A. was incorporated in 1992 and is headquartered in Madrid, Spain. Clínica Baviera, S.A. is a subsidiary of Aier Eye International (Europe), S.L.U.

www.clinicabaviera.com

1,706

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CBAV.MC

View More

Performance Overview: CBAV.MC

Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is IBEX 35... (^IBEX) .

YTD Return

CBAV.MC
25.00%
IBEX 35... (^IBEX)
19.35%

1-Year Return

CBAV.MC
43.42%
IBEX 35... (^IBEX)
23.47%

3-Year Return

CBAV.MC
99.58%
IBEX 35... (^IBEX)
65.13%

5-Year Return

CBAV.MC
398.11%
IBEX 35... (^IBEX)
107.63%

Compare To: CBAV.MC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CBAV.MC

View More

Valuation Measures

As of 5/13/2025
  • Market Cap

    623.74M

  • Enterprise Value

    648.63M

  • Trailing P/E

    15.79

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.38

  • Price/Book (mrq)

    6.44

  • Enterprise Value/Revenue

    2.47

  • Enterprise Value/EBITDA

    8.31

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.13%

  • Return on Assets (ttm)

    17.81%

  • Return on Equity (ttm)

    43.16%

  • Revenue (ttm)

    265.72M

  • Net Income Avi to Common (ttm)

    40.2M

  • Diluted EPS (ttm)

    2.47

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    38.58M

  • Total Debt/Equity (mrq)

    59.67%

  • Levered Free Cash Flow (ttm)

    41.14M

Research Analysis: CBAV.MC

View More

People Also Watch